Form 4 for GYRE GYRE THERAPEUTICS, INC.
Accepted 2022-08-10 00:00:00 ET · period of report 2022-08-09 · accession 0001209191-22-045254 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-10 | 2022-08-09 | GYRE | Miller Seline E. | SVP Fin, Interim CFO, PAO | P - Purchase | $0.47 | +3,250 | 6,500 | +100% | +$1,528 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-09 | P | A | 3,250 | $0.47 | 6,500 | D | — | — | (F1) Shares purchased under the Issuer's 2018 Employee Stock Purchase Plan on August 9, 2022. |